N
Noppadol Siritanaratkul
Researcher at Mahidol University
Publications - 49
Citations - 1494
Noppadol Siritanaratkul is an academic researcher from Mahidol University. The author has contributed to research in topics: Thalassemia & Beta thalassemia. The author has an hindex of 17, co-authored 49 publications receiving 1229 citations.
Papers
More filters
Journal ArticleDOI
Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma
Tadeusz Robak,Huiqiang Huang,Jie Jin,Jun Zhu,Ting Liu,Olga Samoilova,Halyna Pylypenko,Gregor Verhoef,Noppadol Siritanaratkul,Osmanov Ea,Julia Alexeeva,Juliana Pereira,Johannes Drach,Jiri Mayer,Xiaonan Hong,Rumiko Okamoto,Lixia Pei,Brendan Rooney,Helgi van de Velde,Franco Cavalli +19 more
TL;DR: VR-CAP was more effective than R-CHOP in patients with newly diagnosed mantle-cell lymphoma but at the cost of increased hematologic toxicity.
Journal ArticleDOI
Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study
Ali T. Taher,John B. Porter,Vip Viprakasit,Antonis Kattamis,Suporn Chuncharunee,Pranee Sutcharitchan,Noppadol Siritanaratkul,Renzo Galanello,Zeynep Karakas,Tomasz Lawniczek,Jacqueline Ros,Yiyun Zhang,Dany Habr,Maria Domenica Cappellini +13 more
TL;DR: This is the first randomized study showing that iron chelation with deferasirox significantly reduces iron overload in NTDT patients with a frequency of overall adverse events similar to placebo.
Journal ArticleDOI
Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids
Ruchaneekorn W. Kalpravidh,Noppadol Siritanaratkul,Praphaipit Insain,Ratiya Charoensakdi,Narumol Panichkul,Suneerat Hatairaktham,Somdet Srichairatanakool,Chada Phisalaphong,Eliezer A. Rachmilewitz,Suthat Fucharoen +9 more
TL;DR: The increased oxidative stress in beta-thalassemia/Hb E patients was shown by higher levels of MDA, SOD, GSH-Px in RBC, serum NTBI, and lower level of RBC GSH.
Journal ArticleDOI
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
Tarinee Rungjirajittranon,Weerapat Owattanapanich,Patompong Ungprasert,Noppadol Siritanaratkul,Theera Ruchutrakool +4 more
TL;DR: Thrombosis and bleeding are common initial manifestations of Philadelphia (Ph) chromosome-negative myeloproliferative neoplasms and Investigations for MPN should be considered for patients who present with unexplained thrombotic events or abnormal bleeding.
Journal ArticleDOI
Frontline bortezomib, rituximab, cyclophosphamide, doxorubicin, and prednisone (VR-CAP) versus rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) in transplantation-ineligible patients with newly diagnosed mantle cell lymphoma: final overall survival results of a randomised, open-label, phase 3 study
Tadeusz Robak,Jie Jin,Halyna Pylypenko,Gregor Verhoef,Noppadol Siritanaratkul,Johannes Drach,Markus Raderer,Jiri Mayer,Juliana Pereira,Gayane Tumyan,Rumiko Okamoto,Susumu Nakahara,Peter Hu,Carlos Appiani,Sepideh Nemat,Franco Cavalli,Achiel Van Hoof,Adriana Sheliga,Adriana Teixeira,Akihiro Tomita,Albert Oriol Rocafiguera,Alexander Suvorov,Alexy Kuzmin,Ali Khojasteh,Amel Mezlini,Anatoly Golenkov,André Bosly,Andrew Belch,Ann Van De Velde,Árpád Illés,Ashis Mukhopadhyay,Balkis Meddeb,Bernard De Prijck,Bernardo Garichochea,Bulent Undar,Caballero Gabarrón,Carmen Cao,Carmino Antonio De Souza,Charles Farber,Cheol Won Suh,Cristina Ileana Burcoveanu,Cristina Ligia Cebotaru,Cristina-Ligia Truica,Dai Maruyama,David Belada,Dina Ben Yehuda,Dmitry Udovitsa,Dolores,Enrica Morra,Ernst Späth-Schwalbe,Eva Gonzalez-Barca,Osmanov Ea,Francisco Javier Capote,Fritz Offner,Galvez Cardenas,Georg Heß,Georgii Manikhas,Govind Babu,Grigoriy B Rekhtman,Guiseppe Rossi,Herlander Marques,Horia Bumbea,Huaqing Wang,Huiqiang Huang,Ilseung Choi,Irina Bulavina,Irina Lysenko,Irit Avivi,Iryna Kryachok,Jan Maciej Zaucha,Jan Novák,Joaquín Díaz,Judit Demeter,Julia Alexeeva,Jun Zhu,Kateryna Vilchevskaya,Kenichi Ishizawa,Kenny Mauricio,Kensei Tobinai,Kiyoshi Ando,Kudrat Abdulkadryrov,Lee-Yung Shih,Lyudmila Kuzina,Mahmut Gumus,Maike De Wit,Marcelo Capra,Margarida Marques,Marina Golubeva,Mario Ojeda-Uribe,Maryna Kyselyova,Masafumi Taniwaki,Massimo Federico,Michael Crump,Michele Baccarani,Michinori Ogura,Miklos Egyed,Miklos Udvardy,Mitsutoshi Kurosawa,Naokuni Uike,Nuriet Khuageva,Ofer Shpilberg,Oleg Gladkov,Olga Samoilova,Olga Serduk,Patricia Santi,Pierre Zachee,Polina Kaplan,Razvan Stoia,Remy Gressin,Reyes Arranz,Richard Greil,Sebastian Grosicki,Sergio Cancelado,Sreejith Nair,Steven Le Gouill,Steven Van Steenweghen,Sung-Soo Yoon,Suporn Chuncharune,Tatiana Scheider,Tatsu Shimoyama,Ting Liu,Tomohiro Kinoshita,Toshiki Uchida,Udomsak Bunworasate,Umberto Vitolo,Viacheslav Pavlov,Vijay Rao Phooshkooru,Vladimir Lima,Vladimir Merkulov,Weerasak Nawarawong,Xiaonan Hong,Xiaoyan Ke,Yasuhito Terui,Yeow Tee Goh,Yoshiharu Maeda,Yuankai Shi,Yuri Dunaev,Yurii Lorie,Zhao Wang,Zhixiang Shen,Zita Borbenyi,Zoltán Gasztonyi,Zvenyslava Masliak +142 more
TL;DR: Compared with R-CHOP, VR- CAP was associated with significantly longer survival, and had a manageable and expected safety profile, which support further assessment of VR-CAP in patients with previously untreated mantle cell lymphoma.